用Pycnogenol®对手部症状性骨关节炎进行补充治疗
Maria R Cesarone1, Gianni Belcaro2, David Cox1
1Irvine3 Labs and PAP/PEA Screening Project, San Valentino, Pescara, Italy.
Minerva surgery
|July 9, 2024
概括
在4周的时间里,在患有手关节炎的患者中,补充Pycnogenol显著降低了疼痛,并改善了手的力量. 这种自然方法提供了一个耐受良好的替代方案,可能降低了对止痛药的需求.
科学领域:
- 整形外科 整形外科 整形外科
- 类风湿病学 类风湿病学
- 自然产品研究自然产品研究
背景情况:
- 手部骨关节炎 (OA) 是一种常见的疾病,引起疼痛和功能减弱.
- 目前的管理往往涉及疼痛药物与潜在的副作用.
- 天然提取物Pycnogenol (R) 以其抗炎和止痛特性而闻名.
研究的目的:
- 评估Pycnogenol (R) 作为手部OA疼痛标准管理的补充剂的疗效.
- 为了比较Pycnogenol (R) 单独使用标准管理和口服迪克洛芬雅克.
主要方法:
- 一项为期4周的试点注册研究,涉及42名手部OA受试者.
- 一组接受了标准管理,每天增加150毫克Pycnogenol (R).
- 对照组仅接受标准治疗;追溯组使用迪克洛芬雅克.
主要成果:
- 与对照组相比,Pycnogenol (R) 显著减少了早晨,下班后和晚上的疼痛.
- 使用Pycnogenol (R) 显著改善了握力和手部功能.
- 补充Pycnogenol (R) 导致炎症标志物 (ESR,C反应蛋白) 降低,氧化应激减少.
结论:
- 补充Pycnogenol (R) 耐受性很好,有效地控制手部OA疼痛并改善握力.
- 它在某些方面表现出与狄克洛芬雅克相比更高的疗效.
- 皮cnogenol (R) 为手部OA患者提供了一个有前途的,自然的治疗选择.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
194
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
194
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
166
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
166
01:23Hand hygiene
3.2K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Hand washing...
3.2K
01:26Peptic Ulcer Disease IV: Management
85
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
85
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
144
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
144